Mosquito Bites Deliver Potential New Malaria Vaccine, Seattle Biomedical Research Institute Study

free biotech news

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

This study suggests that genetically engineered malaria parasites that are stunted through precise gene deletions (genetically attenuated parasites, or “GAP”) could be used as a vaccine that protects against malaria infection. This means that the harmless (attenuated) version of the parasite would interact with the body in the same way as the infective version, but without possibility of causing disease. GAP-vaccination would induce robust immune responses that protect against future infection with malaria.

Hey, check out all the research scientist jobs. Post your resume today!

MORE ON THIS TOPIC